Patent application number | Description | Published |
20140358619 | TIME-DEPENDENT REORDER POINTS IN SUPPLY CHAIN NETWORKS - According to an exemplary embodiment, a computer-implemented method for attempting to optimize a supply chain network (SCN) includes forecasting demand in the SCN based on a set of demand data. One or more time-dependent reorder points (ROPs) deemed to optimize the SCN are generated by a computer processor, based on the demand forecast, where each time-dependent ROP represents an ROP that changes over time. A simulation of operations of the SCN is performed, using the time-dependent ROPs. | 12-04-2014 |
20140358621 | TIME-DEPENDENT REORDER POINTS IN SUPPLY CHAIN NETWORKS - According to an exemplary embodiment, a computer-implemented method for attempting to optimize a supply chain network (SCN) includes forecasting demand in the SCN based on a set of demand data. One or more time-dependent reorder points (ROPs) deemed to optimize the SCN are generated by a computer processor, based on the demand forecast, where each time-dependent ROP represents an ROP that changes over time. A simulation of operations of the SCN is performed, using the time-dependent ROPs. | 12-04-2014 |
20150149255 | ROBUST PRICING SOLUTION FOR PRODUCTS AND SERVICES - In one embodiment, a computer-implemented method includes identifying a plurality of origin-destination (OD) pairs within a transportation network. A plurality of ranges for price elasticities may be calculated, where the ranges include at least one price elasticity range for each of the OD pairs, and where, for each OD pair, the associated range of the price elasticity spans multiple values. A robustness parameter may be received. A pricing scheme may be calculated, by a computer processor, based at least in part on the robustness parameter, where the pricing scheme includes a price for each of the OD pairs in the network and is at least partially based on the robustness parameter and the plurality of ranges for the price elasticities. | 05-28-2015 |
Patent application number | Description | Published |
20110140450 | Method and Apparatus for Wind Energy System - The present invention relates to generating power using wind energy. According to some aspects, the invention uses a passive device to capture wind, and accelerate the wind toward off-the-shelf turbines and other fan blades to generate power in a confined structure. The passive devices to capture wind can have active electronic or mechanical controls to control the amount of wind flowing in the structure to generate power. | 06-16-2011 |
20110221196 | METHOD AND APPARATUS FOR WIND ENERGY SYSTEM - The description relates to generating power using wind energy. The current disclosure provides an opportunity to develop a new energy generating resource. According to some aspects, the apparatus uses a passive device to capture wind, and accelerate the wind toward a turbine and other fan or turbine blades to generate power in a confined structure. The foot print of the current design is scalable to individual users or businesses such as homes, industrial facilities, small business sites, as well as small power utilities such as wind farms. The passive devices to capture wind can have active electronic or mechanical controls to control the amount of wind flowing in the structure to generate power. | 09-15-2011 |
20120187684 | DEVICE, SYSTEM AND METHOD TO LOWER STARTING TORQUE FOR ELECTRICAL SYSTEM - The present disclosure describes lowering of the starting torque for an alternator or motor. The disclosure also describes the integrated torque management system, torque control logic and torque control method. The current process may be adopted for any motor or alternator that has to manage the starting torque for optimal performance. The disclosure also provides a method, system and a device to allow any energy generating system to rotate at lower speeds to improve the efficiency of power generators. | 07-26-2012 |
Patent application number | Description | Published |
20130023475 | C-MET RECEPTOR REGULATION BY ANGIOTENSIN IV (AT4) RECEPTOR LIGANDS - The cell surface c-Met receptor, through which hepatocyte growth factor (HGF) signals are mediated, has now been identified as the Angiotensin-IV receptor (AT(4)R) in processes that include HGF-regulated cell motility, angiogenesis, cancer metastasis, adipogenesis and others. Disclosed are angiotensin-like factor compositions and methods for using them to diagnose, prevent and/or treat conditions associated with c-Met dysregulation, including cancer, obesity and conditions associated with obesity, and other disorders, for example, by altering hepatocyte growth factor activity or c-Met receptor activity by administering an angiotensin-like factor that specifically binds to a cell surface c-Met receptor. In addition, members of this group of molecules may useful for treating or preventing the development of neurodegenerative diseases like general dementia, Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis and initiating recovery from traumatic brain injury and spinal cord trauma. These peptides and peptidomimetics may be therapeutically useful whenever increased neurotrophic activity would be clinically advantageous. | 01-24-2013 |
20130165392 | HEPATOCYTE GROWTH FACTOR MIMICS AS THERAPEUTIC AGENTS - Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, neurodegenerative disease, diabetes and metabolic syndrome, cancer, and defective wound healing. | 06-27-2013 |
20140051633 | Hepatocyte Growth Factor Mimics as Therapeutic Agents - Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia (e.g. Alzheimer's) and Parkinson's disease. | 02-20-2014 |
20140088004 | Hepatocyte Growth Factor Mimics as Therapeutic Agents - Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, neurodegenerative disease, diabetes and metabolic syndrome, cancer, and defective wound healing. | 03-27-2014 |
20140094413 | HEPATOCYTE GROWTH FACTOR (HGF) MIMICS AS THERAPEUTIC AGENTS - Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, Alzheimer's disease, Parkinson's disease, amyotrphic lateral sclerosis, and other neurodegenerative diseases, spinal cord injury, traumatic brain injury, diabetes and metabolic syndrome, cancer, and defective wound healing. | 04-03-2014 |